Structural and kinetic analysis of the COP9-Signalosome activation and the cullin-RING ubiquitin ligase deneddylation cycle

  1. Ruzbeh Mosadeghi
  2. Kurt M Reichermeier
  3. Martin Winkler
  4. Anne Schreiber
  5. Justin M Reitsma
  6. Yaru Zhang
  7. Florian Stengel
  8. Junyue Cao
  9. Minsoo Kim
  10. Michael J Sweredoski
  11. Sonja Hess
  12. Alexander Leitner
  13. Ruedi Aebersold
  14. Matthias Peter
  15. Raymond J Deshaies
  16. Radoslav I Enchev  Is a corresponding author
  1. University of Southern California, United States
  2. California Instittute of Technology, United States
  3. Swiss Federal Institute of Technology, Switzerland
  4. University of Konstanz, Germany
  5. California Institute of Technology, United States
  6. ETH Zurich, Switzerland

Abstract

The COP9-Signalosome (CSN) regulates cullin-RING ubiquitin ligase (CRL) activity and assembly by cleaving Nedd8 from cullins. Free CSN is autoinhibited, and it remains unclear how it becomes activated. We combine structural and kinetic analyses to identify mechanisms that contribute to CSN activation and Nedd8 deconjugation. Both CSN and neddylated substrate undergo large conformational changes upon binding, with important roles played by the N-terminal domains of Csn2 and Csn4 and the RING domain of Rbx1 in enabling formation of a high affinity, fully active complex. The RING domain is crucial for deneddylation, and works in part through conformational changes involving insert-2 of Csn6. Nedd8 deconjugation and re-engagement of the active site zinc by the autoinhibitory Csn5 glutamate-104 diminish affinity for Cul1/Rbx1 by ~100-fold, resulting in its rapid ejection from the active site. Together, these mechanisms enable a dynamic deneddylation-disassembly cycle that promotes rapid remodeling of the cellular CRL network.

Article and author information

Author details

  1. Ruzbeh Mosadeghi

    Keck School of Medicine, University of Southern California, Los Angeles, United States
    Competing interests
    No competing interests declared.
  2. Kurt M Reichermeier

    Division of Biology and Biological Engineering, California Instittute of Technology, Pasadena, United States
    Competing interests
    No competing interests declared.
  3. Martin Winkler

    Department of Biology, Institute of Biochemistry, Swiss Federal Institute of Technology, Zurich, Switzerland
    Competing interests
    No competing interests declared.
  4. Anne Schreiber

    Department of Biology, Institute of Biochemistry, Swiss Federal Institute of Technology, Zurich, Switzerland
    Competing interests
    No competing interests declared.
  5. Justin M Reitsma

    Division of Biology and Biological Engineering, California Instittute of Technology, Pasadena, United States
    Competing interests
    No competing interests declared.
  6. Yaru Zhang

    Division of Biology and Biological Engineering, California Instittute of Technology, Pasadena, United States
    Competing interests
    No competing interests declared.
  7. Florian Stengel

    Department of Biology, University of Konstanz, Konstanz, Germany
    Competing interests
    No competing interests declared.
  8. Junyue Cao

    Division of Biology and Biological Engineering, California Instittute of Technology, Pasadena, United States
    Competing interests
    No competing interests declared.
  9. Minsoo Kim

    Division of Biology and Biological Engineering, California Instittute of Technology, Pasadena, United States
    Competing interests
    No competing interests declared.
  10. Michael J Sweredoski

    Proteome Exploration Lab, Beckman Institute, California Institute of Technology, Pasadena, United States
    Competing interests
    No competing interests declared.
  11. Sonja Hess

    Proteome Exploration Lab, Beckman Institute, California Institute of Technology, Pasadena, United States
    Competing interests
    No competing interests declared.
  12. Alexander Leitner

    Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zürich, Switzerland
    Competing interests
    No competing interests declared.
  13. Ruedi Aebersold

    Department of Biology, Institute of Molecular Systems Biology, Swiss Federal Institute of Technology, Zürich, Switzerland
    Competing interests
    No competing interests declared.
  14. Matthias Peter

    Department of Biology, Institute of Biochemistry, Swiss Federal Institute of Technology, Zurich, Switzerland
    Competing interests
    No competing interests declared.
  15. Raymond J Deshaies

    Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, United States
    Competing interests
    Raymond J Deshaies, Reviewing editor, eLife.
  16. Radoslav I Enchev

    Department of Biology, Institute of Biochemistry, Swiss Federal Institute of Technology, Zurich, Switzerland
    For correspondence
    radoslav.enchev@bc.biol.ethz.ch
    Competing interests
    No competing interests declared.

Reviewing Editor

  1. J Wade Harper, Harvard Medical School, United States

Version history

  1. Received: October 5, 2015
  2. Accepted: March 30, 2016
  3. Accepted Manuscript published: March 31, 2016 (version 1)
  4. Accepted Manuscript updated: April 2, 2016 (version 2)
  5. Version of Record published: May 23, 2016 (version 3)

Copyright

© 2016, Mosadeghi et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,317
    views
  • 1,119
    downloads
  • 80
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ruzbeh Mosadeghi
  2. Kurt M Reichermeier
  3. Martin Winkler
  4. Anne Schreiber
  5. Justin M Reitsma
  6. Yaru Zhang
  7. Florian Stengel
  8. Junyue Cao
  9. Minsoo Kim
  10. Michael J Sweredoski
  11. Sonja Hess
  12. Alexander Leitner
  13. Ruedi Aebersold
  14. Matthias Peter
  15. Raymond J Deshaies
  16. Radoslav I Enchev
(2016)
Structural and kinetic analysis of the COP9-Signalosome activation and the cullin-RING ubiquitin ligase deneddylation cycle
eLife 5:e12102.
https://doi.org/10.7554/eLife.12102

Share this article

https://doi.org/10.7554/eLife.12102

Further reading

    1. Biochemistry and Chemical Biology
    2. Evolutionary Biology
    Eva Pyrihová, Martin S King ... Edmund RS Kunji
    Research Article

    Stramenopiles form a clade of diverse eukaryotic organisms, including multicellular algae, the fish and plant pathogenic oomycetes, such as the potato blight Phytophthora, and the human intestinal protozoan Blastocystis. In most eukaryotes, glycolysis is a strictly cytosolic metabolic pathway that converts glucose to pyruvate, resulting in the production of NADH and ATP (Adenosine triphosphate). In contrast, stramenopiles have a branched glycolysis in which the enzymes of the pay-off phase are located in both the cytosol and the mitochondrial matrix. Here, we identify a mitochondrial carrier in Blastocystis that can transport glycolytic intermediates, such as dihydroxyacetone phosphate and glyceraldehyde-3-phosphate, across the mitochondrial inner membrane, linking the cytosolic and mitochondrial branches of glycolysis. Comparative analyses with the phylogenetically related human mitochondrial oxoglutarate carrier (SLC25A11) and dicarboxylate carrier (SLC25A10) show that the glycolytic intermediate carrier has lost its ability to transport the canonical substrates malate and oxoglutarate. Blastocystis lacks several key components of oxidative phosphorylation required for the generation of mitochondrial ATP, such as complexes III and IV, ATP synthase, and ADP/ATP carriers. The presence of the glycolytic pay-off phase in the mitochondrial matrix generates ATP, which powers energy-requiring processes, such as macromolecular synthesis, as well as NADH, used by mitochondrial complex I to generate a proton motive force to drive the import of proteins and molecules. Given its unique substrate specificity and central role in carbon and energy metabolism, the carrier for glycolytic intermediates identified here represents a specific drug and pesticide target against stramenopile pathogens, which are of great economic importance.

    1. Biochemistry and Chemical Biology
    Zheng Ruan, Junuk Lee ... Wei Lü
    Research Article

    Protein phosphorylation is one of the major molecular mechanisms regulating protein activity and function throughout the cell. Pannexin 1 (PANX1) is a large-pore channel permeable to ATP and other cellular metabolites. Its tyrosine phosphorylation and subsequent activation have been found to play critical roles in diverse cellular conditions, including neuronal cell death, acute inflammation, and smooth muscle contraction. Specifically, the non-receptor kinase Src has been reported to phosphorylate Tyr198 and Tyr308 of mouse PANX1 (equivalent to Tyr199 and Tyr309 of human PANX1), resulting in channel opening and ATP release. Although the Src-dependent PANX1 activation mechanism has been widely discussed in the literature, independent validation of the tyrosine phosphorylation of PANX1 has been lacking. Here, we show that commercially available antibodies against the two phosphorylation sites mentioned above—which were used to identify endogenous PANX1 phosphorylation at these two sites—are nonspecific and should not be used to interpret results related to PANX1 phosphorylation. We further provide evidence that neither tyrosine residue is a major phosphorylation site for Src kinase in heterologous expression systems. We call on the field to re-examine the existing paradigm of tyrosine phosphorylation-dependent activation of the PANX1 channel.